GM Advisory Group’s cbdMD YCBD Stock Holding History

GM Advisory Group’s Portfolio YCBD Stock Details YCBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-69	Closed	-$148K	–	119
2019 Q2	$148K	Buy	+69	New	+$140K	0.05%	108

Other funds holding YCBD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

GM Advisory Group's YCBD Position: Q3 2019 in Review

GM Advisory Group sold out of cbdMD (YCBD) in Q3 2019, closing a stake of 69 shares — an estimated $148K sold.

GM Advisory Group first reported a position in YCBD in Q2 2019 and held it in 1 quarter. The position peaked at $148K in Q2 2019. 41 funds tracked by Wall St. Rank hold YCBD as of Q3 2019.

GM Advisory Group reported no remaining cbdMD position as of Q3 2019 after selling out during the quarter.
GM Advisory Group sold 69 cbdMD shares in Q3 2019, an estimated $148K.
GM Advisory Group first reported a position in cbdMD in Q2 2019 and held it in 1 quarter.
GM Advisory Group's cbdMD position peaked at $148K in Q2 2019.
41 funds tracked by Wall St. Rank held cbdMD as of Q3 2019.

Based on GM Advisory Group's 13F filing for Q3 2019, filed 14 Nov 2019.